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sient loss of consciousness, documented in the hospital re-mula). Echocardiogram showed no evidence of structuralCase presentation
An 8-year-old female patient was referred to a paediatrician
for assessment of an episode of global muscle weakness after
a 100 m sprint. There was no loss of consciousness. Proximal
hip muscles and shoulder girdle weakness was noted and the
possibility of a myopathy was raised. Muscle biopsy demon-
strated “ultra-structurally normal muscle fibres”. There was
indolent progression of proximal muscle weakness over the
years, with no diagnosis made.
At the age of 18 the patient experienced three episodes of
transient loss of consciousness over a two-week period. A
witness described sudden “unresponsiveness and general-
ised muscle twitching”; a period of confusion consistent with
a post-ictal period was noted. There was no urinary incon-
tinence or tongue biting. No trigger was identified. Inpatientm (M.D. Fryer), Gerald.ka
eart Rhythm Society
on and hosting by Elsevi
se (http://creativecommocord as ‘consistent with seizure activity’ occurred; cardiac
monitoring did not reveal an arrhythmia. A clinical diagnosis
of epilepsy was made based on the description of the epi-
sodes and lack of a symptom rhythm correlation. The patient
was commenced on sodium valproate, which prevented
further episodes.
Surface electrocardiograms recorded during the admission
documented asymptomatic, frequent polymorphic ectopy
Fig. 1.
The QTc was marginally prolonged at 465ms (Bazett's for-
heart disease. An outpatient Holter monitor confirmed the
background rhythm was sinus, with episodes of non-
sustained bidirectional ventricular tachycardia and frequent
multimorphological ventricular ectopy with a 25% ectopic
burden. Ectopy was suppressed completely during treadmill
exercise testing. The effect of exercise on the QT interval was
not recorded. Metoprolol, verapamil, sotalol and flecainide
were sequentially tried, but were either ineffective or pro-
duced intolerable side effects.
At the age of 23 years the patient moved interstate and
was referred for review. She had been seizure-free for 5 years.
Medical background was unremarkable. Family history was
incomplete (patient had no available history from the
paternal side. No abnormalities were noted on the maternal
side). Physical examination revealed short stature, mandib-
ular hypoplasia, hypertelorism and a broad nasal root.
Neurological assessment demonstrated a waddling gait, with
inability to rise from a sitting position without assistance. No
fasciculation or myotonia was evident. Marked proximal
upper and lower limb girdle weakness, Medical Researchye@health.qld.gov.au (G. Kaye), susan.tomlinson@sydney.edu.au
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Fig. 1 e A 12 lead ECG recorded from the patient.
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Distal strength was largely preserved. Reflexes were sym-
metrically depressed. Cardiovascular examination found an
irregular pulse. ECG showed frequent polymorphic ectopy as
before.
A channelopathy for the cause of her frequent ventricular
ectopy and syncope was postulated. Catecolaminergic poly-
morphic ventricular tachycardia (CPVT), was an obvious
consideration, however the suppression of the ectopy during
an exercise stress test, essentially excluded this diagnosis.
Brugada syndrome and arrhythmogenic right ventricular
cardiomyopathy were thought less likely as the ECG didn't
show features typically associated with these disorders. The
long QT syndrome although associated with polymorphic
ventricular tachycardia, is not generally described with
frequent ventricular extrasystoles at rest or bidirectional
ventricular tachycardia. This patient not only had frequent
multifocal ectopy, but had a documented episode of bi-
directional ventricular tachycardia, a feature well described
in the Andersen-Tawil syndrome. The baseline ECG didn't
demonstrate the classic prominent U waves that have been
documented in other ATS patients.Fig. 2 e Holter monitor tracing demonstrating an episode oAll the above channelopathies, besides ATS, are not tradi-
tionally reported with muscle weakness or facial dys-
morphism and given the specific documented cardiac
arrhythmias a clinical diagnosis of Andersen-Tawil syndrome
was made.
In light of the lack of seizures for 5 years, the anti-epileptic
medication was discontinued. Six months later, the patient
experienced recurrent syncope, without convulsive activity.
The patient described these episodes as different from those
she had suffered at the age of 18. Holter monitoring, recorded
peri-event, showed non-sustained runs of bidirectional ven-
tricular tachycardia, as well as monomorphic ventricular
tachycardia Fig. 2.
Due to accelerated symptomotology, positive ECG correla-
tion and the clinical difference from previous syncope, an
internal cardiac defibrillator (ICD) was advised. Immediately
prior to implantation the patient became pregnant. She
continued to suffer recurrent syncope and, at the beginning of
the second trimester, an ICD was implanted. A pectoral
muscle biopsy was sent for genetic analysis. This confirmed a
mutation in c.652C > T of the KCNJ2 gene, previously reported
in the Andersen-Tawil syndrome [1].f non-sustained bidirectional ventricular tachycardia.
Fig. 3 e Portion of the electrogram from interrogation of the patients' ICD on admission to hospital following discharge of the
device demonstrating a tachycardia in the VT/VF zone.
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u rn a l 1 5 ( 2 0 1 5 ) 1 5 8e1 6 1160After implantation the patient experienced further syn-
cope. The internal electrogram recorded during the episode
showed no sustained arrhythmia. Witnesses described
convulsive activity and symptoms consistent with a post ictal
period and the possibility of a concurrent seizure disorder was
raised. Sodium valproate was reinitiated and, to date, there
have been no further seizures.
Eight months later the patient developed recurrent poly-
morphic ventricular tachycardia resulting in repeated shocks
Fig. 3.
The majority of these occurred either at the onset of or
during sleep, consistent with a hypothesis generated in a
previous case report [2], that autonomic instability might
precipitate haemodynamically compromising ventricular ar-
rhythmias in patients with Andersen-Tawil syndrome. The
device was reprogrammed to allow a longer delay before
shock delivery resulting in long self terminating runs of
polymorphic ventricular tachycardia associated with pre-
syncope. Carvedilol and flecainide were commenced, and
effectively suppressed ectopy but produced severe headaches
requiring cessation. Mexiletine was of no benefit. Hence due
to failure of medical treatment, left stellate ganglionectomy
was performed. However, frequent ectopy and infrequent
episodes of symptomatic polymorphic ventricular tachy-
cardia continued unabated, though fortunately programming
of the ICD has avoided recurrent shocks.Discussion
This case report describes a 23-year old female with recurrent
syncope, the Andersen-Tawil syndrome and concomitant
epilepsy. ATS is a rare genetic disorder first described in 1971
by Dr. Ellen Andersen [3] in an 8-year old boy. Dr Rabi Tawil
subsequently clarified the underlying genetic abnormalities as
well as setting out diagnostic criteria [4]. The underlying ge-
netic abnormality in 60% of cases relates to a missense mu-
tation in KCNJ2 (detected on chromosome 17q23) [5], a gene
that encodes for the inward potassium rectifier channel Kir 2.1(IK1), leading to prolongation of the terminal phase of the
cardiac action potential. This genetic defect can result in
“terminal phase” early after depolarisations, which is thought
to be demonstrated by the recurrent ventricular ectopy aswell
as prominent U waves on the surface ECG [4].
The inheritance of ATS is autosomal dominant, though
there is incomplete penetrance [2]. Approximately 20% of
those with a KCNJ2 mutation are asymptomatic. Conversely,
up to 40% of patients with the clinical phenotype are negative
for mutations involving KCNJ2.
The QT interval is not consistently prolonged in these pa-
tients and thus some authors have discontinued using the
previous designation of long QT 7 [6].
The diagnosis of ATS is based upon three specific features:
dysmorphic abnormalities such as hypognathia, clinodactyly,
short stature, hypertelorism, low set ears, single palmar
crease and cryptochordism [7], periodic paralysis and frequent
ventricular extrasystoles [3]. A diagnosis of ATS can be made
when two of the above three criteria are met. In a patient with
only one of the above additional evidence, such as an affected
family member is required [8].
No specific features of the syndrome predict the severity of
arrhythmic burden or risk of sudden cardiac death (SCD). In
one study consisting of 96 patients, the incidence of Torsades
de pointes was approximately 3% [9].
Typically, periodic paralysis presents before other com-
ponents of the disordermanifest themselves. The average age
of onset of muscle weakness is 5 years of age compared to 13
years of age for cardiac arrhythmias. This may explain the
difficulty in formal diagnosis. There is no documented relation
to other potassium sensitive forms of periodic paralysis. As in
this patient, weakness following prolonged exertion is com-
mon and muscle biopsies, generally, have no specific abnor-
malities [10]. The underlying defect in skeletal muscle is also
due to a mutation in the IK1 channel.
The cardiac features are now thought to be due to a
channelopathy that results in varying degrees of ventricular
arrhythmias [10] ranging from frequent multimorphological
ectopy to bidirectional ventricular tachycardia to polymorphic
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burden (up to 65% of patients in one cohort had evidence of
non-sustained ventricular tachycardia) [9]; the majority of
patients with ATS are asymptomatic [7]. Changes on the sur-
face ECG include: prominent Uwaves in the anterior leads (not
associated with bradycardia or hypokalemia), increased T-U
junction and prolongation of the terminal, down sloping
portion of the T wave [9]. Sudden death is rare and much less
than that associated with other channelopathies such as the
Long QT or Brugada syndromes [2].
Differentiating cardiac syncope from other forms of tran-
sient loss of consciousness can be difficult. Features more
suggestive of cardiac origin include preceding feelings of light-
headedness/diaphoresis, palpitations or chest pain. Theymay
also be associated with activities such as prolonged standing/
sitting or micturition etc. Transient loss of consciousness
associated with a seizure may demonstrate a preceding aura
(visual/auditory/olfactory), involve tongue biting, urinary in-
continence, post ictal period and even focal neurological
deficits.
Convulsive syncope can be particularly difficult to discern
a cause as global hypoperfusion of the brain leads to syncope,
but also associated convulsive activity.
Although it was initially felt that this patients' recurrent
syncope was cardiac in origin, the absence of a recorded
arrhythmia, convulsive activity and post-ictal periods during
some of the episodes and eyewitness accounts, strongly sug-
gested epilepsy as an additional diagnosis. Since recom-
mencing sodium valproate, no further seizures have occurred.
Although, an increased incidence of epilepsy is not reported in
patients with ATS and occurrence in this patient may reflect
the background prevalence of epilepsy in the general popu-
lation. It could also represent the expression of her ion
channelopathy in neural tissues. Recent publications have
intimated a deficit in abstract reasoning and executive func-
tion suggesting subtle cerebral abnormalities in patients with
ATS [11]. Although it is possible that the Kir 2.1 mutation,
which leads to the missense mutation in potassium channels
in cardiac myocytes, may also affect similar channels in the
brain. To the author's knowledge, it has not been proven
whether this defect results in seizures.
This case is unusual because of the significant resistance
to anti-arrhythmic medication. Only flecainide suppressed
the frequency of ectopy and bidirectional ventricular tachy-
cardia, but could not be tolerated by the patient (The efficacy
of flecainide in reducing ectopy has been noted in other in-
dividual cases of ATS) [12,13]. Beta-blockers also could not
be tolerated. Stellate ganglionectomy was considered even
though the episodes occurred at rest, because she was
symptomatic with frequent episodes of polymorphic ven-
tricular tachycardia and had failed available medical
treatment.
Currently there are no specific guidelines for the implan-
tation of an ICD in patients with Andersen-Tawil syndrome.
Current consensus is that patients who are survivors of a
cardiac arrest, have recurrent syncope or sustained, symp-
tomatic ventricular tachyarrhythmias should be considered
for ICD implantation [4].The fetus was tested and demonstrated the samemutation
as the proband, but to date has not experienced cardiac ar-
rhythmias, although she does have the proximal muscle
weakness and the waddling gait (currently 5 years-old).
In summary this case highlights the complexities of man-
aging a patient with Andersen-Tawil syndrome manifesting
as refractory arrhythmia and profound proximal weakness.
The patient had concurrent epilepsy, which resulted in clini-
cally different episodes from those caused by the arrhythmia.
The case illustrates the importance of awareness of the clin-
ical features of this syndrome, and in managing concomitant
medical issues. We encourage other groups to report their
experience of seizures, in patients with the ATS, to promote
further research into the link between KCNJ2 mutations and
neurological disorders.r e f e r e n c e s
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